P07333 (CSF1R_HUMAN) Homo sapiens (Human)
Macrophage colony-stimulating factor 1 receptor UniProtKBInterProSTRINGInteractive Modelling
972 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of the extracellular domain of human CSF-1 receptor in complex with the Fab fragment of R… |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 1×SO4; | ||||
| Assess | ||||||
| Structure of the human CSF-1:CSF-1R complex |
Heteromer P09603; | |||||
| Assess | ||||||
| Structure of the human CSF-1:CSF-1R complex |
Heteromer P09603; | 2×NAG; 1×NAG; 2×NAG; 1×SIA; 3×NAG; | ||||
| Assess | ||||||
| Crystal Structure of Human Interleukin-34 Bound to Human CSF-1R |
Heteromer Q6ZMJ4; | 2×NAG; 2×BMA; 4×NAG; | ||||
| Assess | ||||||
| Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain | monomer | |||||
| Assess | ||||||
| cFMS tyrosine kinase (tie2 KID) in complex with an arylamide inhibitor | monomer | 1×5CN; | ||||
| Assess | ||||||
| cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor | monomer | 3×SO4; 1×IXH; | ||||
| Assess | ||||||
| Structure of CSF1R in complex with a pyrollopyrimidine (compound 23) | monomer | 1×LMR; 1×GOL; 1×UIK; | ||||
| Assess | ||||||
| c-FMS tyrosine kinase in complex with a quinolone inhibitor | monomer | 1×SO4; 1×6C3; | ||||
| Assess | ||||||
| Crystal structure of CSF-1R kinase domain with sulfatinib | monomer | 1×UKI; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397 | monomer | 1×P31; | ||||
| Assess | ||||||
| cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-pi… | monomer | 1×ACT; 1×KRJ; | ||||
| Assess | ||||||
| Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4) | monomer | 1×M9T; 4×SO4; | ||||
| Assess | ||||||
| cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor | monomer | 1×5CN; | ||||
| Assess | ||||||
| cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2… | monomer | 1×KRL; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952 | monomer | 2×MG; 1×GOL; 1×A7O; | ||||
| Assess | ||||||
| cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor | monomer | 3×SO4; 1×8C5; | ||||
| Assess | ||||||
| Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R | monomer | 1×LC0; | ||||
| Assess | ||||||
| Crystal structure of CSF1R kinase domain in complex with DP-6233 | monomer | 1×NA; 4×CL; 1×I9W; | ||||
| Assess | ||||||
| CSF1R signaling is a regulator of pathogenesis in progressive MS | monomer | 1×UF4; | ||||
| Assess | ||||||
| Inhibitor Bound to A DFG-In structure of the Kinase Domain of CSF-1R | monomer | 2×SO4; 1×BDY; | ||||
| Assess | ||||||
| Crystal structure of fms kinase domain with a small molecular inhibitor, PLX5622 | monomer | 1×622; | ||||
| Assess | ||||||
| Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME | monomer | 1×64M; | ||||
| Assess | ||||||
| Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC | monomer | 1×STI; | ||||
| Assess | ||||||
| Crystal structure of CSF1R in complex with vimseltinib | monomer | 1×Z6V; | ||||
| Assess | ||||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4liq.1.A | monomer | 0.79 | 100.00 | |||
| Assess | ||||||
| 4wrm.1.A | monomer | 0.76 | 100.00 | |||
| Assess | ||||||
| 2i1m.1.A | monomer | 0.67 | 1×5CN; | 94.17 | ||
| Assess | ||||||
| 8dfm.1.A | monomer | 0.62 | 44.69 | |||
| Assess | ||||||
| 2ogv.1.A | monomer | 0.51 | 86.94 | |||
| Assess | ||||||
9 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4wrm.1.A | monomer | 0.85 | 97.89 | ||
| Assess | ||||||
| Isoform 2 | 4liq.1.A | monomer | 0.84 | 98.01 | ||
| Assess | ||||||
| Isoform 2 | 4yfd.1.B | monomer | 0.56 | 18.32 | ||
| Assess | ||||||
| Isoform 2 | 6fwx.1.A | monomer | 0.55 | 18.05 | ||
| Assess | ||||||
| Isoform 2 | 7pkl.1.B | monomer | 0.54 | 15.04 | ||
| Assess | ||||||
| Isoform 2 | 4yfg.1.B | monomer | 0.54 | 18.32 | ||
| Assess | ||||||
| Isoform 2 | 4y61.1.A | monomer | 0.53 | 18.25 | ||
| Assess | ||||||
| Isoform 2 | 5xwt.1.A | monomer | 0.53 | 18.18 | ||
| Assess | ||||||
| Isoform 2 | 7ceg.1.A | monomer | 0.50 | 18.32 | ||
| Assess | ||||||